Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

633,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remote Short Sessions of Heart Rate Variability Biofeedback Monitored With Wearable Technology: Open-Label Prospective Feasibility Study.
Hirten RP, Danieletto M, Landell K, Zweig M, Golden E, Pyzik R, Kaur S, Chang H, Helmus D, Sands BE, Charney D, Nadkarni G, Bagiella E, Keefer L, Fayad ZA. Hirten RP, et al. JMIR Ment Health. 2024 Apr 25;11:e55552. doi: 10.2196/55552. JMIR Ment Health. 2024. PMID: 38663011
Numerical improvement in psychological metrics was observed over the 17-week study period, although it did not reach statistical significance (all P>.05). Using a mixed effect cosinor model, the mean midline-estimating statistic of rhythm (MESOR) of the circadian patter …
Numerical improvement in psychological metrics was observed over the 17-week study period, although it did not reach statistical significanc …
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
Abbadessa G, Lepore MT, Bruzzaniti S, Piemonte E, Miele G, Signoriello E, Perna F, De Falco C, Lus G, Matarese G, Bonavita S, Galgani M. Abbadessa G, et al. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200250. doi: 10.1212/NXI.0000000000200250. Epub 2024 Apr 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38662990
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.
Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Bozhinov PS, Vitt D, Kohlhof H, Slizgi J, Ondrus M, Sciacca V, Muehler AR; EMPhASIS investigators. Fox RJ, et al. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200208. doi: 10.1212/NXI.0000000000200208. Epub 2024 Apr 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38662979 Clinical Trial.
Follow-up and Mediation Outcomes of a Movement-Based Mental Health Promotion Intervention for Refugee Children in Uganda.
Jordans MJD, Koppenol-Gonzalez GV, Bleile ACE, Orech B, Brian A, Verreault K. Jordans MJD, et al. J Clin Child Adolesc Psychol. 2024 Apr 25:1-12. doi: 10.1080/15374416.2024.2344157. Online ahead of print. J Clin Child Adolesc Psychol. 2024. PMID: 38662956
Intent-to-treat analyses demonstrated sustained benefits for TeamUp for well-being (estimated mean difference -1.88, 95% CI -3.14 to -0.66, p = .003, effect size Cohen's d = 0.25) and friendships (-1.52, 95% CI -2.55 to -0.48, p = .005, d = 0.25). ...S …
Intent-to-treat analyses demonstrated sustained benefits for TeamUp for well-being (estimated mean difference -1.88, 95% CI -3.14 to -0.66, …
Safety and Efficacy of Vocacapsaicin for Management of Postsurgical Pain: A Randomized Clinical Trial.
Shafer SL, Teichman SL, Gottlieb IJ, Singla N, Minkowitz HS, Leiman D, Vaughn B, Donovan JF. Shafer SL, et al. Anesthesiology. 2024 Apr 25. doi: 10.1097/ALN.0000000000005027. Online ahead of print. Anesthesiology. 2024. PMID: 38662910
During the first 96 hours, vocacapsaicin 0.30 mg/mL reduced pain at rest by 33% vs. placebo (primary endpoint, 95% CI [10%, 52%], effect size (Cohen's D) = 0.61, p = 0.005). Twenty-six percent of patients receiving vocacapsaicin 0.30 mg/mL did not require postoperat …
During the first 96 hours, vocacapsaicin 0.30 mg/mL reduced pain at rest by 33% vs. placebo (primary endpoint, 95% CI [10%, 52%], effect siz …
A Biomechanical Comparison of the Back Squat and Hexagonal Barbell Deadlift.
Stahl CA, Regni G, Tanguay J, McElfresh M, Trihy E, Diggin D, King DL. Stahl CA, et al. J Strength Cond Res. 2024 May 1;38(5):815-824. doi: 10.1519/JSC.0000000000004729. J Strength Cond Res. 2024. PMID: 38662880

Stahl, CA, Regni, G, Tanguay, J, McElfresh, M, Trihy, E, Diggin, D, and King, DL. A biomechanical comparison of the back squat and hexagonal barbell deadlift. ...Results showed that subjects lifted greater 1RM loads in the HBD relative to the BS (p < 0.05; d

…
Stahl, CA, Regni, G, Tanguay, J, McElfresh, M, Trihy, E, Diggin, D, and King, DL. A biomechanical comparison of the back squat and he …
633,679 results
You have reached the last available page of results. Please see the User Guide for more information.